Article ; Online: Randomized, placebo controlled study of the effect of propentofylline on survival time and quality of life of cats with feline infectious peritonitis.
Journal of veterinary internal medicine
2011 Volume 25, Issue 6, Page(s) 1270–1276
Abstract: ... survival time in cats with FIP, and increase their quality of life.: Animals: Twenty-three privately ... an effect of PPF on the survival time, the quality of life, or any clinical or laboratory parameter in cats ... with feline infectious peritonitis (FIP).: Hypothesis: Propentofylline (PPF) can decrease vasculitis, and therefore prolong ...
Abstract | Background: Currently there is no drug proven to effectively treat cats with feline infectious peritonitis (FIP). Hypothesis: Propentofylline (PPF) can decrease vasculitis, and therefore prolong survival time in cats with FIP, and increase their quality of life. Animals: Twenty-three privately owned cats with FIP. Methods: Placebo-controlled double-blind trial. FIP was confirmed by histology or immunostaining of feline coronavirus (FCoV) antigen in effusion or tissue macrophages or both. The cats were randomly selected for treatment with either PPF or placebo. All cats received additional treatment with glucocorticoids, antibiotics, and low molecular weight heparin according to methods. Results: There was no statistically significant difference in the survival time of cats treated with PPF (8 days, 95% CI 5.4-10.6) versus placebo (7.5 days, 95% CI 4.4-9.6). The median survival time of all cats was 8 days (4-36 days). There was neither a difference in quality of life (day 7, P = .892), in the amount of effusion (day 7, P = .710), the tumor necrosis factor-alpha (TNF-α) concentration (day 7, P = .355), nor in any other variable investigated in this study, including a complete blood count, and a small animal biochemistry profile. Conclusions and clinical importance: This study did not detect an effect of PPF on the survival time, the quality of life, or any clinical or laboratory parameter in cats with FIP. Therefore, PPF does not appear to be an effective treatment option in cats with a late stage of the disease FIP. |
|||||
---|---|---|---|---|---|---|
MeSH term(s) | Animals ; Anti-Ulcer Agents/therapeutic use ; Cats ; Feline Infectious Peritonitis/blood ; Feline Infectious Peritonitis/drug therapy ; Quality of Life ; Tumor Necrosis Factor-alpha/blood ; Xanthines/therapeutic use | |||||
Chemical Substances | Anti-Ulcer Agents ; Tumor Necrosis Factor-alpha ; Xanthines ; propentofylline (5RTA398U4H) | |||||
Keywords | covid19 | |||||
Language | English | |||||
Publishing date | 2011-10-12 | |||||
Publishing country | United States | |||||
Document type | Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't | |||||
ZDB-ID | 92798-3 | |||||
ISSN | 1939-1676 ; 0891-6640 | |||||
ISSN (online) | 1939-1676 | |||||
ISSN | 0891-6640 | |||||
DOI | 10.1111/j.1939-1676.2011.00806.x | |||||
Shelf mark |
|
|||||
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 4095: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.